(VIANEWS) – Global Ship Lease (GSL), Brooks Automation (BRKS), Microchip Technology (MCHP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Global Ship Lease (GSL)

35.5% sales growth and 12.61% return on equity

Global Ship Lease, Inc. owns and charters containerships of various sizes under fixed-rate charters to container shipping companies.

Global Ship Lease’s sales growth this year is anticipated to be 27.7% and 29% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 296.34M for the twelve trailing months.

Volume

Today’s last reported volume for Global Ship Lease is 686172 which is 4.88% above its average volume of 654185.

Global Ship Lease’s sales growth for the next quarter is 35.5%. The company’s growth estimates for the present quarter and the next is 33.3% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.61%.

Volatility

Global Ship Lease’s last day, last week, and last month’s current volatility was 0.44%, 1.62%, and 2.71%, respectively.

Global Ship Lease’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.94% (day), 5.57% (last week), and 5.25% (last month), respectively.

Global Ship Lease’s Stock Yearly Top and Bottom Value

Global Ship Lease’s stock is valued at $18.35 at 20:22 EST, way under its 52-week high of $22.02 and way higher than its 52-week low of $4.91.

Global Ship Lease’s Moving Average

Global Ship Lease’s worth is above its 50-day moving average of $18.05 and way higher than its 200-day moving average of $15.71.

2. Brooks Automation (BRKS)

27.3% sales growth and 7.71% return on equity

Brooks Automation, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide.

Brooks Automation’s sales growth this year is anticipated to be 29% and 11.4% for next year.

Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 1B for the twelve trailing months.

Volume

Today’s last reported volume for Brooks Automation is 461044 which is 45.4% below its average volume of 844518.

Brooks Automation’s sales growth is a negative 0% for the present quarter and 27.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 115.6% and 42.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.71%.

Volatility

Brooks Automation’s last day, last week, and last month’s current volatility was 1.84%, 0.97%, and 1.63%, respectively.

Brooks Automation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.37% (day), 2.78% (last week), and 3.18% (last month), respectively.

Brooks Automation’s Stock Yearly Top and Bottom Value

Brooks Automation’s stock is valued at $88.77 at 20:22 EST, way below its 52-week high of $108.72 and way above its 52-week low of $42.65.

Brooks Automation’s Moving Average

Brooks Automation’s worth is below its 50-day moving average of $91.04 and below its 200-day moving average of $90.17.

3. Microchip Technology (MCHP)

25.9% sales growth and 8.69% return on equity

Microchip Technology Incorporated develops, manufactures, and sells semiconductor products for various embedded control applications in the Americas, Europe, and Asia.

Microchip Technology’s sales growth this year is anticipated to be 16.6% and 5.6% for next year.

Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 5.7B for the twelve trailing months.

Volume

Today’s last reported volume for Microchip Technology is 1437890 which is 21.93% below its average volume of 1841800.

Microchip Technology’s sales growth is a negative 0% for the current quarter and 25.9% for the next. The company’s growth estimates for the current quarter and the next is 21.8% and 27.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.69%.

Volatility

Microchip Technology’s last day, last week, and last month’s current volatility was 0.03%, 1.32%, and 1.78%, respectively.

Microchip Technology’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.25% (day), 2.36% (last week), and 2.62% (last month), respectively.

Microchip Technology’s Stock Yearly Top and Bottom Value

Microchip Technology’s stock is valued at $149.73 at 20:22 EST, way below its 52-week high of $166.67 and way above its 52-week low of $95.53.

Microchip Technology’s Moving Average

Microchip Technology’s worth is higher than its 50-day moving average of $143.77 and higher than its 200-day moving average of $149.50.

4. Owens & Minor (OMI)

20.5% sales growth and 27.7% return on equity

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally.

Owens & Minor’s sales growth this year is anticipated to be 15.6% and a negative 1.3% for next year.

Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 8.68B for the twelve trailing months.

Volume

Today’s last reported volume for Owens & Minor is 2980260 which is 137.33% above its average volume of 1255700.

Owens & Minor’s sales growth is a negative 0% for the present quarter and 20.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 385% and negative -9.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.7%.

Volatility

Owens & Minor’s last day, last week, and last month’s current volatility was 9.68%, 3.34%, and 2.16%, respectively.

Owens & Minor’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.09% (day), 5.20% (last week), and 4.39% (last month), respectively.

Owens & Minor’s Stock Yearly Top and Bottom Value

Owens & Minor’s stock is valued at $42.76 at 20:22 EST, way under its 52-week high of $49.16 and way above its 52-week low of $12.54.

Owens & Minor’s Moving Average

Owens & Minor’s worth is below its 50-day moving average of $44.32 and way higher than its 200-day moving average of $37.14.

5. Eli Lilly and Company (LLY)

15% sales growth and 118.34% return on equity

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide.

Eli Lilly and Company’s sales growth this year is anticipated to be 10.9% and 2.3% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 25.49B for the twelve trailing months.

Volume

Today’s last reported volume for Eli Lilly and Company is 1900660 which is 42.02% below its average volume of 3278520.

Eli Lilly and Company’s sales growth for the next quarter is 15%. The company’s growth estimates for the ongoing quarter and the next is 1.6% and 22.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 118.34%.

Volatility

Eli Lilly and Company’s last day, last week, and last month’s current volatility was 0.66%, 1.80%, and 1.02%, respectively.

Eli Lilly and Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.60% (day), 3.39% (last week), and 2.07% (last month), respectively.

Eli Lilly and Company’s Stock Yearly Top and Bottom Value

Eli Lilly and Company’s stock is valued at $263.44 at 20:22 EST, under its 52-week high of $270.65 and way above its 52-week low of $129.21.

Eli Lilly and Company’s Moving Average

Eli Lilly and Company’s worth is way above its 50-day moving average of $235.55 and way above its 200-day moving average of $207.15.

6. Balchem Corporation (BCPC)

11.1% sales growth and 10.81% return on equity

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally.

Balchem Corporation’s sales growth this year is expected to be 7.1% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 743.87M for the twelve trailing months.

Volume

Today’s last reported volume for Balchem Corporation is 69918 which is 32.85% below its average volume of 104137.

Balchem Corporation’s sales growth for the next quarter is 11.1%. The company’s growth estimates for the current quarter and the next is 3.5% and 13.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.81%.

Volatility

Balchem Corporation’s last day, last week, and last month’s current volatility was 0.81%, 0.91%, and 0.82%, respectively.

Balchem Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.23% (day), 2.25% (last week), and 1.80% (last month), respectively.

Balchem Corporation’s Stock Yearly Top and Bottom Value

Balchem Corporation’s stock is valued at $130.92 at 20:22 EST, below its 52-week high of $139.59 and way higher than its 52-week low of $92.60.

Balchem Corporation’s Moving Average

Balchem Corporation’s value is below its 50-day moving average of $131.51 and higher than its 200-day moving average of $126.21.

7. American Water Works (AWK)

7.6% sales growth and 11.2% return on equity

American Water Works Company, Inc., through its subsidiaries, provides water and wastewater services in the United States.

American Water Works’s sales growth this year is expected to be 6.5% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 3.82B for the twelve trailing months.

Volume

Today’s last reported volume for American Water Works is 1000340 which is 41.9% above its average volume of 704911.

American Water Works’s sales growth is a negative 0% for the ongoing quarter and 7.6% for the next. The company’s growth estimates for the present quarter and the next is 12.4% and 6.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.2%.

Volatility

American Water Works’s last day, last week, and last month’s current volatility was 1.81%, 1.22%, and 1.09%, respectively.

American Water Works’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.32% (day), 2.05% (last week), and 1.93% (last month), respectively.

American Water Works’s Stock Yearly Top and Bottom Value

American Water Works’s stock is valued at $177.45 at 20:22 EST, below its 52-week high of $180.42 and way higher than its 52-week low of $131.01.

American Water Works’s Moving Average

American Water Works’s worth is higher than its 50-day moving average of $163.45 and way higher than its 200-day moving average of $155.71.

8. Novo Nordisk A/S (NVO)

7.2% sales growth and 75.94% return on equity

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.

Novo Nordisk A/S’s sales growth this year is anticipated to be 7.1% and 7% for next year.

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 126.88B for the twelve trailing months.

Volume

Today’s last reported volume for Novo Nordisk A/S is 1746970 which is 84.98% above its average volume of 944360.

Novo Nordisk A/S’s sales growth for the next quarter is 7.2%. The company’s growth estimates for the current quarter and the next is 6.9% and 5.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.94%.

Volatility

Novo Nordisk A/S’s last day, last week, and last month’s current volatility was 0.56%, 0.90%, and 0.89%, respectively.

Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.76% (day), 1.05% (last week), and 1.07% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $99.48 at 20:22 EST, higher than its 52-week high of $92.18.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is way higher than its 50-day moving average of $85.13 and way higher than its 200-day moving average of $76.14.

Previous days news about Novo Nordisk A/S(NVO)

According to Business Insider on Wednesday, 4 August, "Danish pharmaceutical company Novo Nordisk A/S (NVO) Wednesday reported first-half net profit of 24.75 billion Danish krone or 10.71 krone per share, up from last year’s 22.52 billion krone or 9.58 krone per share."

LEAVE A REPLY

Please enter your comment!
Please enter your name here